Highcape Capital, L.P. has bought stock on 2 days since Dec 2022
Director and 10% owner at Elutia Inc., and 1 other company
SEC CIK 0001826279 · Filings on SEC.gov ↗
Highcape Capital, L.P.'s record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
2 filings since Dec 2022, newest first
About Highcape Capital, L.P.
HighCape Capital, L.P. is a prominent investment firm specializing in the life sciences sector, recognized as a significant shareholder and 10% owner in Elutia Inc. (NASDAQ: ELUT).( On February 3, 2025, HighCape Capital acquired 420,000 shares of Elutia’s Class A Common Stock at $2.50 per share, totaling $1.05 million, increasing its holdings to 9,520,232 shares, reflecting its strategic confidence in Elutia’s growth potential in biological products development.(
The firm operates through a network of affiliated entities, including HighCape Partners QP, L.P., HighCape Capital, LLC, and HighCape Co-Investment Vehicles I and II, LLC, all designated as 10% owners and directors in SEC filings.( HighCape maintains substantial ownership in Elutia, with reports indicating up to 18.98 million shares or 44-46% of the company, underscoring its active involvement in biotech investments.( Its history includes consistent engagement with Elutia, formerly Aziyo Biologics, through purchases and distributions among partners.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.